<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2022</study_start_year><condition>Metastatic Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><disease>Metastatic Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/879</full_dataset_link><location>Egypt</location><study_start_month>12</study_start_month><keyword>Silymarin</keyword><repository>ECRIN MDR</repository><study_status>Not yet recruiting</study_status></additional><is_claimable>false</is_claimable><name>Effect of Silymarin in Metastatic Colorectal Cancer Patients</name><description>this work is aim to assess the antitumor effect of silymarin in patients with metastatic colorectal cancer receiving chemotherapy with or without target therapy (Bevacizumab).</description><dates><creation>2022-12-15</creation></dates><accession>879</accession><cross_references><ClinicalTrials___gov>NCT05631041</ClinicalTrials___gov></cross_references></HashMap>